Global connected diabetes care leader Glooko, Inc. announced the launch of GestationalCare™ – a dedicated, pregnancy‑specific clinical module built on its existing ambulatory diabetes management platform. The new offering is aimed at clinicians who manage high‑risk pregnancies complicated by diabetes, providing a single, automated view of patient data across multiple monitoring devices.
Clinicians have long struggled with compressed clinical timelines inherent to pregnancy, often juggling disconnected spreadsheets, patient‑portal screenshots, and handwritten paper logs. These fragmented workflows increase the risk of data entry errors and delay critical treatment adjustments, a problem that GestationalCare is designed to eliminate.
ALSO READ | Food Bank for NYC Urges Congress to Halt SNAP Cost Shift and Fully Fund Emergency Aid
GestationalCare aggregates data from any compatible glucose‑monitoring device, presenting it in a unified, real‑time dashboard that is independent of the manufacturer. By automating data capture, the module removes the need for manual transcription and enables care teams to focus on clinical decision‑making rather than data reconciliation.
Gestational diabetes affects a significant proportion of pregnant women and requires tight glycemic control to safeguard both maternal and fetal health. Because the physiological changes of pregnancy compress the window for therapeutic interventions, timely, accurate telemetry is essential. GestationalCare’s device‑neutral architecture ensures that clinicians can monitor trends, set alerts, and adjust treatment plans without the lag caused by disparate data sources.
The module is available exclusively to Glooko’s paid‑plan customers. According to the company, the rollout will begin with onboarding sessions for health systems and diabetes clinics that already use the platform, allowing them to integrate GestationalCare into existing workflows without additional infrastructure costs.
